Chronological primacy of oxidative stress in Alzheimer disease

Neurobiology of Aging

Volumn 26, Issue 5, 2005, Pages 579-580

  Smith, Mark A ^a   Nunomura, Akihiko ^b   Lee, Hyoung Gon ^a   Zhu, Xiongwei ^a   Moreira, Paula I ^a   Avila, Jesús ^c   Perry, George ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT;

AGE; ALZHEIMER DISEASE; BIOACCUMULATION; CELL POPULATION; CELL SPECIFICITY; ENZYME ACTIVITY; GENOTYPE; HEREDITY; NERVE CELL; NOTE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RISK FACTOR; TREATMENT FAILURE;

EID: 13644249113     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2004.09.021     Document Type: Note

References (34)

1. M.P. Mattson, J.W. Carney, and D.A. Butterfield A tombstone in Alzheimer's? Nature 373 6514 1995 481
2. A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, and E.K. Balraj Oxidative damage is the earliest event in Alzheimer disease J Neuropathol Exp Neurol 60 8 2001 759 767
3. D. Pratico, C.M. Clark, F. Liun, J. Rokach, V.Y. Lee, and J.Q. Trojanowski Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease Arch Neurol 59 6 2002 972 976
4. L. Migliore, I. Fontana, F. Trippi, R. Colognato, F. Coppede, and G. Tognoni Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients Neurobiol Aging 2004
5. P. Odetti, G. Angelini, D. Dapino, D. Zaccheo, S. Garibaldi, and F. Dagna-Bricarelli Early glycoxidation damage in brains from Down's syndrome Biochem Biophys Res Commun 243 3 1998 849 851
6. G.E. Gibson, K.F. Sheu, J.P. Blass, A. Baker, K.C. Carlson, and B. Harding Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease Arch Neurol 45 1988 836 840
7. G. Perry, R.J. Castellani, M.A. Smith, P.L. Harris, Z. Kubat, and K. Ghanbari Oxidative damage in the olfactory system in Alzheimer's disease Acta Neuropathol (Berl) 106 6 2003 552 556
8. H.A. Ghanbari, K. Ghanbari, P.L. Harris, P.K. Jones, Z. Kubat, and R.J. Castellani Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients Aging Cell 3 1 2004 41 44
9. M.A. Smith, L.M. Sayre, M.P. Vitek, V.M. Monnier, and G. Perry Early Ageing and Alzheimer's Nature 374 6520 1995 316
10. L.M. Sayre, D.A. Zelasko, P.L. Harris, G. Perry, R.G. Salomon, and M.A. Smith 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease J Neurochem 68 5 1997 2092 2097
11. A. Nunomura, G. Perry, M.A. Pappolla, R. Wade, K. Hirai, and S. Chiba RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease J Neurosci 19 6 1999 1959 1964
12. X. Zhu, A.K. Raina, G. Perry, and M.A. Smith Alzheimer's disease: the two-hit hypothesis Lancet Neurol 3 4 2004 219 226
13. G.J. Wilde, A.K. Pringle, P. Wright, and F. Iannotti Differential vulnerability of the CA1 and CA3 subfields of the hippocampus to superoxide and hydroxyl radicals in vitro J Neurochem 69 2 1997 883 886
14. M. Bernaudin, A. Nouvelot, E.T. MacKenzie, and E. Petit Selective neuronal vulnerability and specific glial reactions in hippocampal and neocortical organotypic cultures submitted to ischemia Exp Neurol 150 1 1998 30 39
15. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, and M. Grundman A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease ooperative Study N Engl J Med 336 17 1997 1216 1222
16. C.A. Rottkamp, A. Nunomura, K. Hirai, L.M. Sayre, G. Perry, and M.A. Smith Will antioxidants fulfill their expectations for the treatment of Alzheimer disease? Mech Ageing Dev 116 2-3 2000 169 179
17. P.P. Zandi, J.C. Anthony, A.S. Khachaturian, S.V. Stone, D. Gustafson, J.T. Tschanz Cache County Study Group Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the cache county study Arch Neurol 61 1 2004 82 88
18. C.A. Rottkamp, A.K. Raina, X. Zhu, E. Gaier, A.I. Bush, and C.S. Atwood Redox-active iron mediates amyloid-beta toxicity Free Radic Biol Med 30 4 2001 447 450
19. A. Nunomura, G. Perry, M.A. Pappolla, R.P. Friedland, K. Hirai, and S. Chiba Neuronal oxidative stress precedes amyloid-beta deposition in down syndrome J Neuropathol Exp Neurol 59 11 2000 1011 1017
20. D. Pratico, K. Uryu, S. Leight, J.Q. Trojanoswki, and V.M. Lee Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis J Neurosci 21 12 2001 4183 4187
21. E. Tamagno, P. Bardini, A. Obbili, A. Vitali, R. Borghi, and D. Zaccheo Oxidative stress increases expression and activity of BACE in NT2 neurons Neurobiol Dis 10 3 2002 279 288
22. M.A. Smith, G. Casadesus, J.A. Joseph, and G. Perry Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain Free Radic Biol Med 33 9 2002 1194 1199
23. K. Zou, J.S. Gong, K. Yanagisawa, and M. Michikawa A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage J Neurosci 22 2002 4833 4841
24. H.G. Lee, G. Casadesus, X. Zhu, J.A. Joseph, G. Perry, and M.A. Smith Perspectives on the amyloid-beta cascade hypothesis J Alzheimers Dis 6 2 2004 137 145
25. X. Zhu, C.A. Rottkamp, H. Boux, A. Takeda, G. Perry, and M.A. Smith Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease J Neuropathol Exp Neurol 59 10 2000 880 888
26. X. Zhu, A.K. Raina, H.G. Lee, M. Chao, A. Nunomura, and M. Tabaton Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways Antioxid Redox Signal 5 5 2003 571 576 [review]
27. A. Gomez-Ramos, J. Diaz-Nido, M.A. Smith, G. Perry, and J. Avila Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells J Neurosci Res 71 6 2003 863 870
28. R.A. Floyd, and K. Hensley Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases Neurobiol Aging 23 5 2002 795 807
29. M. Miyata, and J.D. Smith Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides Nat Genet 14 1 1996 55 61
30. B. Mazur-Kolecka, J. Frackowiak, D. Kowal, J. Krzeslowska, and D. Dickson Oxidative protein damage in cells engaged in beta-amyloidosis is related to apoE genotype Neuroreport 13 4 2002 465 468
31. C. Cecchi, C. Fiorillo, S. Sorbi, S. Latorraca, B. Nacmias, and S. Bagnoli Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients Free Radic Biol Med 33 10 2002 1372 1379
32. C.A. Rottkamp, C.S. Atwood, J.A. Joseph, A. Nunomura, G. Perry, and M.A. Smith The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease Peptides 23 7 2002 1333 1341
33. C.A. Marques, U. Keil, A. Bonert, B. Steiner, C. Haass, and W.E. Muller Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway J Biol Chem 278 30 2003 28294 28302
34. F. Li, N.Y. Calingasan, F. Yu, W.M. Mauck, M. Toidze, and C.G. Almeida Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice J Neurochem 89 5 2004 1308 1312